Beijing Hotgen Biotech Co Ltd
SSE:688068
Beijing Hotgen Biotech Co Ltd
SSE:688068
Price:
30.19 CNY
5.01%
Market Closed
Updated:
May 29, 2024
Beijing Hotgen Biotech Co Ltd
Capital Expenditures
|
Beijing Hotgen Biotech Co Ltd
Capital Expenditures Peer Comparison
Comparables:
603259
300759
2269
300347
M
688114
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Beijing Hotgen Biotech Co Ltd
SSE:688068
|
Capital Expenditures
-¥413.4m
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-58%
|
CAGR 10-Years
N/A
|
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Capital Expenditures
-¥5.1B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Capital Expenditures
-¥2.6B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
N/A
|
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Capital Expenditures
-¥4.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Capital Expenditures
-¥341.7m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-30%
|
|
M
|
MGI Tech Co Ltd
SSE:688114
|
Capital Expenditures
-¥938.4m
|
CAGR 3-Years
-64%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Beijing Hotgen Biotech Co Ltd's Capital Expenditures?
Capital Expenditures
-413.4m
CNY
-413.4m
CNY
Based on the financial report for Dec 31, 2023, Beijing Hotgen Biotech Co Ltd's Capital Expenditures amounts to -413.4m CNY.
What is Beijing Hotgen Biotech Co Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-58%
-58%
Over the last year, the Capital Expenditures growth was 27%. The average annual Capital Expenditures growth rates for Beijing Hotgen Biotech Co Ltd have been -34% over the past three years , -58% over the past five years .
You don't have any saved screeners yet
